Ferring Laboratories Profile
Key Indicators
- Authorised Capital ₹ 910.00 Cr
as on 21-12-2024
- Paid Up Capital ₹ 744.82 Cr
as on 21-12-2024
- Company Age 8 Year, 11 Months
- Last Filing with ROC 31 Dec 2023
- Revenue 11797518.48%
(FY 2023)
- Profit -2120836.56%
(FY 2023)
- Ebitda -2191556.90%
(FY 2023)
- Net Worth 20857702.37%
(FY 2023)
- Total Assets 21699282.95%
(FY 2023)
About Ferring Laboratories
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 December 2023. It's a company limited by shares with an authorized capital of Rs 910.00 Cr and a paid-up capital of Rs 744.82 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Ferring Laboratories Private Limited India is Rohit Somani as COMPANY SECRETARY. Anindya Ghosh and Jens Regelin serve as directors at the Company.
- CIN/LLPIN
U74120TG2016PTC151173
- Company No.
271931
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
11 Jan 2016
- Date of AGM
12 Jun 2024
- Date of Balance Sheet
31 Dec 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Rangareddy, Telangana, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Ferring Laboratories?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Anindya Ghosh  | Managing Director | 05-Mar-2020 | Current |
| Rohit Somani | Company Secretary | 21-Apr-2023 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jens Regelin  | Director | 29-Oct-2020 | Current |
Financial Performance of Ferring Laboratories.
Ferring Laboratories Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 11797518.48% increase. The company also saw a substantial fall in profitability, with a 2120836.56% decrease in profit. The company's net worth Soared by an impressive increase of 20857702.37%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ferring Laboratories?
In 2023, Ferring Laboratories had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Ferring Therapeutics Private LimitedActive 13 years 26 daysAnindya Ghosh and Jens Regelin are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Ferring Laboratories?
Ferring Laboratories has a workforce of 44 employees as of Mar 28, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ferring Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ferring Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
